- Home
- CHRS vs DWSN Comparison
CHRS vs DWSN Comparison
Compare CHRS & DWSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- DWSN
- Stock Information
- Founded
- CHRS 2010
- DWSN 1952
- Country
- CHRS United States
- DWSN United States
- Employees
- CHRS N/A
- DWSN N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- DWSN Oil & Gas Production
- Sector
- CHRS Health Care
- DWSN Energy
- Exchange
- CHRS Nasdaq
- DWSN Nasdaq
- Market Cap
- CHRS 102.0M
- DWSN 89.9M
- IPO Year
- CHRS 2014
- DWSN N/A
- Fundamental
- Price
- CHRS $1.05
- DWSN $1.29
- Analyst Decision
- CHRS Buy
- DWSN
- Analyst Count
- CHRS 3
- DWSN 0
- Target Price
- CHRS $4.68
- DWSN N/A
- AVG Volume (30 Days)
- CHRS 1.5M
- DWSN 72.4K
- Earning Date
- CHRS 08-07-2025
- DWSN 08-12-2025
- Dividend Yield
- CHRS N/A
- DWSN N/A
- EPS Growth
- CHRS N/A
- DWSN N/A
- EPS
- CHRS 1.55
- DWSN N/A
- Revenue
- CHRS $272,209,000.00
- DWSN $55,987,000.00
- Revenue This Year
- CHRS N/A
- DWSN N/A
- Revenue Next Year
- CHRS $142.61
- DWSN N/A
- P/E Ratio
- CHRS $2.05
- DWSN N/A
- Revenue Growth
- CHRS 52.33
- DWSN N/A
- 52 Week Low
- CHRS $0.66
- DWSN $1.08
- 52 Week High
- CHRS $2.43
- DWSN $5.54
- Technical
- Relative Strength Index (RSI)
- CHRS 62.88
- DWSN 40.73
- Support Level
- CHRS $0.81
- DWSN $1.33
- Resistance Level
- CHRS $0.95
- DWSN $1.41
- Average True Range (ATR)
- CHRS 0.07
- DWSN 0.06
- MACD
- CHRS 0.01
- DWSN -0.01
- Stochastic Oscillator
- CHRS 85.71
- DWSN 7.25
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About DWSN Dawson Geophysical Company
Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.